Your account is not claimed yet. You can sign up with ORCID to claim your account.

Milind A Phadnis

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 17

Top Venues

Kidney360

Journal of biopharmaceutical statistics

Biometrical journal. Biometrische Zeitschrift

Sleep disorders

University of Kansas Medical Center

University of Alabama at Birmingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Kansas Medical Center

United States

Assistant Professor (Tenure Track) :: Biostatistics

Education History

University of Alabama at Birmingham

United States

PHD :: Biostatistics

Publications

Palash Sharma, Milind A Phadnis
Stochastic curtailment tests for phase II trial with time-to-event outcome using the concept of relative time in the case of non-proportional hazards. Journal of biopharmaceutical statistics (2023)
Muhammad Waleed, Jianghua He, Milind A Phadnis
Sample size reestimation and Bayesian predictive probability for single-arm clinical trials with a time-to-event endpoint using Weibull distribution with unknown shape parameter. Journal of biopharmaceutical statistics (2023)
Nishank Jain, Bradley C Martin, Junqiang Dai, Milind A Phadnis, Layth Al-Hindi, Theresa I Shireman, S Susan Hedayati, Rafia S Rasu, Jawahar Lal Mehta
Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y 12 Inhibitors in Patients Receiving Dialysis. Kidney360 3 (8) (2022)
Adam Corken, Jerry Ware, Junqiang Dai, John M Arthur, Susan Smyth, Clayton L Davis, Juan Liu, Terry O Harville, Milind A Phadnis, Jawahar Lal Mehta, Yasir Rahmatallah, Nishank Jain
Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study. Kidney360 3 (12) (2022)
Adam Corken, Jerry Ware, Junqiang Dai, John M Arthur, Susan Smyth, Clayton L Davis, Juan Liu, Terry O Harville, Milind A Phadnis, Jawahar Lal Mehta, Yasir Rahmatallah, Nishank Jain
Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study. Kidney360 3 (12) (2022)
Adam Corken, Jerry Ware, Junqiang Dai, John M Arthur, Susan Smyth, Clayton L Davis, Juan Liu, Terry O Harville, Milind A Phadnis, Jawahar Lal Mehta, Yasir Rahmatallah, Nishank Jain
Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study. Kidney360 3 (12) (2022)
Elise Hoover, Ronald D Perrone, Chris Rusconi, Beverly Benson, Neera K Dahl, Berenice Gitomer, Amy Manelli, Michal Mrug, Meyeon Park, Stephen L Seliger, Milind A Phadnis, Nadeesha Thewarapperuma, Terry J Watnick
Design and Basic Characteristics of a National Patient-Powered Registry in ADPKD. Kidney360 3 (8) (2022)
Adam Corken, Jerry Ware, Junqiang Dai, John M Arthur, Susan Smyth, Clayton L Davis, Juan Liu, Terry O Harville, Milind A Phadnis, Jawahar Lal Mehta, Yasir Rahmatallah, Nishank Jain
Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study. Kidney360 3 (12) (2022)
Milind A Phadnis, Matthew S Mayo
Sample size calculation for two-arm trials with time-to-event endpoint for nonproportional hazards using the concept of Relative Time when inference is built on comparing Weibull distributions. Biometrical journal. Biometrische Zeitschrift 63 (7) (2021)
Muhammad Waleed, Jianghua He, Milind A Phadnis
Some design considerations incorporating early futility for single-arm clinical trials with time-to-event primary endpoints using Weibull distribution. Pharmaceutical statistics 20 (3) (2021)
Priyanka Sharma, Vandana G Abramson, Anne O'Dea, Lauren Nye, Ingrid Mayer, Harsh B Pathak, Marc Hoffmann, Shane R Stecklein, Manana Elia, Sharon Lewis, Jecinta Scott, Jilliann A De Jong, Yen Y Wang, Rachel Yoder, Kelsey Schwensen, Karissa Finke, Jaimie Heldstab, Stephanie LaFaver, Stephen K Williamson, Milind A Phadnis, Gregory A Reed, Bruce F Kimler, Qamar J Khan, Andrew K Godwin
Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Milind A Phadnis, Matthew S Mayo
Sample size calculations for noninferiority trials for time-to-event data using the concept of proportional time. Journal of applied statistics 48 (6) (2020)
Mohammed M Alshehri, Abdulaziz A Alkathiry, Aqeel M Alenazi, Shaima A Alothman, Jason L Rucker, Milind A Phadnis, John M Miles, Patricia M Kluding, Catherine F Siengsukon
Sleep Efficiency and Total Sleep Time in Individuals with Type 2 Diabetes with and without Insomnia Symptoms. Sleep disorders 2020 (2020)
Mohammed M Alshehri, Aqeel M Alenazi, Shaima A Alothman, Jason L Rucker, Milind A Phadnis, John M Miles, Catherine F Siengsukon, Patricia M Kluding
Using Cognitive Behavioral Therapy for Insomnia in People with Type 2 Diabetes, Pilot RCT Part I: Sleep and Concomitant Symptom. Behavioral sleep medicine 19 (5) (2020)
Mohammed M Alshehri, Aqeel M Alenazi, Jeffrey C Hoover, Shaima A Alothman, Milind A Phadnis, Jason L Rucker, Christie A Befort, John M Miles, Patricia M Kluding, Catherine F Siengsukon
Effect of Cognitive Behavioral Therapy for Insomnia on Insomnia Symptoms for Individuals With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial. JMIR research protocols 8 (12) (2019)
Milind A Phadnis, Matthew S Mayo
Group sequential design for time-to-event data using the concept of proportional time. Statistical methods in medical research 29 (7) (2019)
Milind A Phadnis, James B Wetmore, Matthew S Mayo
A clinical trial design using the concept of proportional time using the generalized gamma ratio distribution. Statistics in medicine 36 (26) (2017)

Milind A Phadnis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Milind A Phadnis